General Terms and Conditions

BEFORE PLACING AN ORDER OR USING THIS PRODUCT, PLEASE READ THE TERMS AND CONDITIONS SET FORTH IN THE TERMS AND CONDITIONS. YOUR USE OF THIS PRODUCT SHALL CONSTITUTE ACKNOWLEDGMENT AND ACCEPTANCE OF THESE TERMS AND CONDITIONS.

Price: The price for any product (hereinafter "Product") or service (herein after “Service”) shall be the price stated in the Knudra Project Plan Quotation. Knudra bills on a 50/50 service pay plan for full-build projects. The first 50% is paid up front and is unrefundable. The second 50% is paid at end of project and is only billable per line if a line type is delivered. For all other project types (Inject Express, Transgenic Capture, and evaluation of guide RNA cutting), payment is due for project start. Knudra quotations are valid for thirty (30) days unless otherwise stated in the quotation. Prices stated are exclusive of all taxes, fees, licenses, duties or levies and, unless otherwise stated in the quotation, transportation charges, freight and insurance. The attached quotation supersedes/cancels all previous quotations on the Products and Services stated in the quotation and the quotation number must be referenced on your purchase order.

Shipping and Handling: Unless specifically quoted, shipping and handling charges will be prepaid and added to the invoice (PPD & Add). Wet Ice, Hazardous and Dry Ice packaging, if requested by client, will be prepaid and added to all invoices as appropriate.

Sales Tax: Applicable state sales tax will be added to your order. If you have Tax Exempt status, please forward a copy of your exemption certificate with your first order.

Payment Terms: Payment terms are Net 30 days for clients and customers with an established account. For all other customers, payment terms are as indicated on the attached quotation. A 5% fee accrued monthly is added to invoices not paid within 30 day grace period. Make sure to create wires in USD for value on invoice. Failure to make a payment with deposit value not matching invoice will result in a $100 fee added on all subsequent invoices.

Strain Nomenclature: At the request of WormBase, genetic variation generated and recovered by Knudra should retain the “knu # “ allele designation provided. Allele names can be ascertained from either product shipping documents or by emailing Knudra.

Confidentiality: Knudra keeps client's Information with the same degree of care it holds its own confidential information, including written Information relating to the services, data; know-how; assay methods; technical and non-technical materials. Knudra will not use the Information except for the services to be performed pursuant to the client's order. Knudra will disclose the Information only to its officers, employees and affiliates directly concerned with the services, but will neither disclose the Information to any third party nor use the Information for any other purpose unless such materials: i. were known to Knudra prior to the order, as evidenced by Knudra's written records; ii. are or become generally available to the public through no fault of Knudra; iii. are received by Knudra in good faith from a third party, not in breach of an obligation of confidentiality; iv. are independently developed, discovered or arrived at by Knudra without use of or reference to Confidential Information; or v. are disclosed, pursuant to a requirement of law. Only with expressed and written permission from client, will specific items of Information be made available for marketing purposes only.

Force Majeure: Knudra shall not be liable for any delay or failure of performance, including without limitation, failure to deliver or failure to install, where such delay or failure arises or results from any cause beyond Knudra’s reasonable control, including, but not limited to, flood, unusually severe weather, earthquake or other act of nature, power loss, strike, boycott, or other labor disputes, embargo, governmental regulation, or an inability or delay in obtaining materials. In the event of any such delay or failure of performance, Knudra shall have such additional time within which to perform its obligations hereunder as may be reasonably necessary under the circumstances.

Repeat Attempts: For any given step in Project Plan, events may occur that cause step failure. Knudra will repeat the step again at its own expense. If the step fails a second time, Knudra will contact the client to get advice on a third repeat. Upon authorization for a third repeat at the step, Knudra will perform the third repeat at its own expense. If the step fails to give desired result on the third attempt, the client will be contacted and a Revised Project Plan will be implemented at a client expense that covers the additional cost of materials and labor needed in accomplishing the workaround procedure. Generation of one line constitutes completion of a project. If additional lines are requested, the client will be responsible for the cost of additional injections and screening.

Indemnification: Knudra shall indemnify its client, employees, directors and officers for any claims for injuries to persons or damages, which occur on Knudra’s premises or premises under the exclusive control of Knudra. Knudra's client shall defend, indemnify and hold harmless Knudra, its employees, directors and officers, from and against any and all liability, which it may incur, by reason of client's use of the results of the services hereunder.

Limitation of Liability: Knudra’s liability shall be limited to the price paid by you for the Knudra products and services on the relevant sales transaction. Except as prohibited by law, in no event shall Knudra be liable for any incidental or consequential damages or for lost profits, loss of data, or for any other claim, expense, liability or loss otherwise arising from any sale of products and services to you.

Limited License: Use of transgenic deliverables by client recipient as Limited Licensee may be covered by by various issued and pending patents (ex. patent # US8937213). Use of this product, and materials for creation and detection of transgenics including, but not restricted to, plasmids vectors, ODNs, RNAs, nucleases and transgenesis modification reagents, shall constitute acknowledgment and acceptance of Limited Licensee as a non-exclusive, non-transferable license of the Product, Progeny (meaning any unmodified descendant form of the Product), Modifications (meaning any modifications of the Product) and Unmodified Derivatives (meaning any substances created by the limited Licensee which constitutes an unmodified functional subunit or product expressed by the Product) for RESEARCH USE ONLY. No “Commercial Use” is allowed. Commercial use means any and all uses of the Product, Progeny, Modifications or Unmodified Derivatives thereof, by the Limited Licensee for monetary or other consideration, including but not limited to: (1) Sale or transfer, whether or not such sale or transfer is limited for use in research; (2) Provision of a service to a third party; (3) Use in any diagnostic, preventative, or therapeutic application; (4) Use in any veterinary, livestock or agricultural application; (5) Use in discovery and comercialization of therapeutic molecules and their compositions; and (6) Manufacturing of a product for sale. Any and all rights to the Product, Progeny, Modifications or Unmodified Derivatives thereof, shall remain in Knudra. No ownership rights are transferred. Data generated by the Limited Licensee using the Product, Progeny, Modifications or Unmodified Derivatives thereof, are owned by the Limited Licensee, subject to the use restrictions above. Limited Licensee shall have no right to transfer or grant sub-licenses under this license. The Product, Progeny, Modifications or Unmodified Derivatives thereof, licensed to the limited Licensee must at all times remain in the possession of the limited Licensee, except that Licensee may transfer to other researchers, either directly or through not-for-profit stock centers, for academic and non-commercial research purposes.

Dispute Resolution. Any dispute arising from the delivery, use, or inadequacy of product shall be resolved amicably by good faith discussions between the parties of client and Knudra. If a party delivers written notice to the other party of any such dispute, the parties shall promptly convene a meeting, either in person or by telephone conference or videoconference, to attempt in good faith to resolve such dispute. Any dispute arising out of or in connection with this Agreement, including any question regarding its existence, validity or termination, that is not resolved by the parties within 30 days after a party’s delivery to the other party of notice of such dispute shall, upon the written request of either party, be referred to and finally resolved by arbitration. The arbitration shall be determined by a single, independent, impartial arbitrator, as chosen by affirmation of each party. The seat, or legal place, of arbitration shall be a location agreed between the parties. The language to be used in the arbitral proceedings shall be English. The decision of the arbitrator shall be final, binding and non-appealable, except in the case of manifest error and judgment may be entered upon it in any court of competent jurisdiction, and subject to the aforesaid, the parties hereby exclude any rights of application or appeal to any court to the extent that they may validly so agree and in particular in connection with any question of law. The arbitrator shall determine the proportions in which the parties shall pay the costs of the arbitration procedure. The arbitrator shall have the authority to order that all or a part of the legal or other costs of a party incurred in relation to the arbitration shall be paid by the other party. Nothing contained in this Agreement shall deny either party the right to seek injunctive or other equitable relief from a court of competent jurisdiction in the context of a bona fide emergency or prospective irreparable harm, and such an action may be filed and maintained notwithstanding any ongoing discussions between the parties or any ongoing arbitration proceeding.